DLA Piper advises SoftBank Group in its Series E investment into Guardant Health
DLA Piper represented SoftBank Group International, the investment arm of Tokyo-based telecommunications and internet company Softbank, in connection with its US$360 million Series E investment and associated joint venture into Guardant Health, a Silicon Valley-based world leader in comprehensive liquid biopsies.